eli lilly and company retatrutide Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight A1C Lilly shares safety, tolerability data
Pay in 4 interest-free payments of $6.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21


























